Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ramesh Chintala"'
Autor:
Christopher D. Mensch, Akhilesh Bhambhani, Denise K. Nawrocki, Ramesh Chintala, Jeffrey T. Blue
Publikováno v:
Journal of Pharmaceutical Sciences. 110:97-107
Despite a consistent benefit of existing pneumococcal conjugate vaccine (PCV) on invasive pneumococcal disease and pneumonia across different epidemiological settings a tremendous gap exists towards global PCV coverage. Currently, no lyophilized dosa
Autor:
Sheng-Ching Wang, Ramesh Chintala, Christopher D. Mensch, Jeffrey T. Blue, William J. Smith, Marc D. Wenger, Patrick L. Ahl
Publikováno v:
PDA Journal of Pharmaceutical Science and Technology. 72:149-162
Aluminum containing adjuvants have been widely used in vaccine formulations to safely and effectively potentiate the immune response. The examination of the extent of antigen adsorption to aluminum adjuvant is always evaluated during the development
Autor:
Amartya Basu, Hsien-Ching Liu, Karen Yang, Ramesh Chintala, Anthony Martinez, Ahsen Janjua, Maoliang Wang, David Filpula, Hong Zhao
Publikováno v:
Bioconjugate Chemistry. 17:341-351
The utility of PEGylation for improving therapeutic protein pharmacology would be substantially expanded if the authentic protein drugs could be regenerated in vivo. Diminution of kinetic constants of both enzymes and protein ligands are commonly enc
Autor:
Ping Peng, Manickam Viswanathan, Amartya Basu, Ahsen Janjua, Xiguang Li, Dechun Wu, Hong Zhao, Zhihua Zhang, John Zhou, Jun Liu, Magda Mendez, Maoliang Wang, Zhenfan Zhang, Jack Hua, Karen Yang, David Filpula, Gerald Petti, Ramesh Chintala, Virna Borowski, Clifford Longley, Thomas Palm, Mary Mehlig, Sam Liu, Ming-Ching Hsieh
Publikováno v:
Bioconjugate chemistry. 17(3)
Recombinant interferon-beta-1b (IFN-beta-1b) is used clinically in the treatment of multiple sclerosis. In common with many biological ligands, IFN-beta-1b exhibits a relatively short serum half-life, and bioavailability may be further diminished by
Autor:
Gerald Petti, Haleema Janjua, John Zhou, Jack Hua, Maoliang Wang, Mark Li, Magda Mendez, Clifford Longley, Ramesh Chintala, Zhenfan Zhang, Ming-Ching Hsieh, Hnin Phyu, Sam Liu, Ping Peng, Virna Borowski, David Filpula, Amartya Basu, Karen Yang, Mary Mehlig
Publikováno v:
Protein engineering. 16(10)
The utility of single-chain Fv proteins as therapeutic agents would be realized if the circulating lives of these minimal antigen-binding polypeptides could be both prolonged and adjustable. We have developed a general strategy for creating tailored
Autor:
Karen Yang, Amartya Basu, Maoliang Wang, Ramesh Chintala, Ming-Ching Hsieh, Sam Liu, Jack Hua, Zhenfan Zhang, John Zhou, Mark Li, Hnin Phyu, Gerald Petti, Magda Mendez, Haleema Janjua, Ping Peng, Clifford Longley, Virna Borowski, Mary Mehlig, David Filpula
Publikováno v:
Protein Engineering; Oct2003, Vol. 16 Issue 10, p761, 10p
Autor:
Ramesh, Chintala, Malarvannan, Pannirselvam, Jayakumar, Rajadas, Jayasundar, Shanmugasundaram, Puvanakrishnan, Rengarajulu
Publikováno v:
Molecular & Cellular Biochemistry; Oct1998, Vol. 187 Issue 1/2, p173-182, 10p
Autor:
Ramesh CV; Department of Biotechnology, Central Leather Research Institute, Adyar, Madras 600020, India., Kamini NR, Puvanakrishnan R
Publikováno v:
Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2004 Dec; Vol. 40 (Pt 3), pp. 271-5.